Caas Capital Management LP Catalyst Biosciences, Inc. Transaction History

Caas Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.55 - $7.29 $708,748 - $1.14 Million	-155,769 Closed	0 $0
Q3 2020 Nov 09, 2020	SELL	$4.22 - $6.04 $851,389 - $1.22 Million	-201,751 Reduced 56.43%	155,769 $670,000
Q2 2020 Aug 14, 2020	BUY	$3.76 - $8.01 $1.34 Million - $2.86 Million	357,520 New	357,520 $2.1 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.